Verenium Corporation (VRNM) Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2012
3/28/2013 6:41:12 AM
SAN DIEGO, March 14, 2013 /PRNewswire/ -- Verenium Corporation (the "Company") (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced certain preliminary financial results for its year ended December 31, 2012. The Company intends to provide fourth quarter and full year audited 2012 financial results on Wednesday, March 27, 2013 after market close.
comments powered by